Efpeglenatide is a

GLP-1 receptor agonist Glucagon-like peptide-1 (GLP-1) receptor agonists, also known as GLP-1 analogs, GLP-1RAs, or incretin mimetics, are a class of anorectic drugs that reduce blood sugar and energy intake by activating the GLP-1 receptor. They mimic the actions of ...

under development for the treatment of type 2 diabetes and obesity and reducing the risk of cardiovascular incidents in people with these conditions. Its developer is Hanmi Pharmaceutical.

References

GLP-1 receptor agonists Experimental diabetes drugs Peptide therapeutics Amino acids {{gastrointestinal-drug-stub